Klareskog L, Gaubitz M, Rodríguez-Valverde V et al.
Karolinska Institutet, Stockholm, Sweden.
Clin Exp Rheumatol 2011;29:238–47.
Editor’s note: Tumor necrosis factor (TNF) inhibitor treatment has become a well-established method of treating rheumatoid arthritis (RA). Concerns still remain about the long-term safety and efficacy of this therapy, such as the incidence of serious opportunistic infections, malignancy, mortality, and morbidity. This study sought to address these concerns.